Results 81 to 90 of about 6,730 (183)

This Is Not a Myeloproliferative Neoplasm…

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
Stephanie Juané Kennedy
wiley   +1 more source

P1666: EFFECT OF AGONISTS TO THROMBOPOIETIN RECEPTORS ON PLATELET GLYCOME OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA

HemaSphere, 2022
E. Monzón Manzano, M. T. Alvarez Román, P. Acuña, E. G. Arias Salgado, A. Ramírez, M. Martín Salces, M. I. Rivas Pollmar, A. González Ceberino, N. V. Butta, V. Jiménez Yuste   +9 more
doaj   +1 more source

TRANSCRIPTOMIC PROFILING SUGGESTS DYSREGULATED ACTIVATION OF B AND T LYMPHOCYTES IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

Hematology, Transfusion and Cell Therapy
Introduction and aims: Myeloproliferative neoplasms (MPN) are clonal hematological diseases characterized by exacerbated proliferation of cells belonging to the myeloid lineage. Gain of function driver mutations in the Janus Kinase 2 (JAK2), calreticulin
VL Bassan, RFM Felício, KCR Malmegrim, FA Castro   +3 more
doaj   +1 more source

Novel Perspectives on Thrombopoietin Receptor Agonists Applications

Hämostaseologie
Abstract Second-generation thrombopoietin receptor agonists (TPO-RAs), romiplostim, eltrombopag, and avatrombopag, have been proved to be significant stimulators of megakaryopoiesis and, in the last decade, they have been incorporated in the treatment options against refractory immune thrombocytopenia in children and adults that do ...
Stafylidis, Christos, Vlachopoulou, Dimitra, Syriopoulou, Stavroula, Chatzidavid, Sevastianos, Viniou, Nora-Athina   +4 more
openaire   +3 more sources

Thrombopoietin Receptor [PDF]

, 2020
openaire   +1 more source

[Biology of thrombopoietin and its receptors].

Postepy higieny i medycyny doswiadczalnej, 1997
Megakaryocytopoiesis is regulated by a number of cytokines with either stimulatory or inhibitory effects. Thrombopoietin (TPO), a cytokine with specific megakaryocyte maturational activity recently has been identified as the c-Mpl ligand. The physiological role of TPO and its potential mechanism of regulation has been investigated by generating mice ...
openaire   +1 more source

Real-world use of thrombopoietic agents in treatment-naïve children with severe aplastic anemia: a multicenter retrospective study. [PDF]

Sci Rep
Chazli YE, Abdallah G, Zakaria M, Darwish A, Khalifa G, Hassan T, Elhawary E, Elbahy S, Salama M, Alrawas A, Wali Y, Zeid M.   +11 more
europepmc   +1 more source

Romiplostim-N01 for cancer therapy-induced thrombocytopenia: A propensity score-matched cohort study. [PDF]

Medicine (Baltimore)
Yu T, Xiong Z, Su Y, Jian Y, Liu L, Wang Y.   +5 more
europepmc   +1 more source

The thrombopoietin receptor

Japanese Journal of Thrombosis and Hemostasis, 2015
openaire   +2 more sources

MPL receptor dimerization and the thrombopoietin pathway in primary immune thrombocytopenia: from molecular mechanisms to targeted therapies. [PDF]

Front Med (Lausanne)
Wang Y, Liu C, Hu Y, Sun X, Zhang W, Zhu W.   +5 more
europepmc   +1 more source